Exelixis EXEL Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's short-term investments?
- Exelixis (EXEL) reported short-term investments of $551.06M in Q1 2026.
- How has Exelixis's short-term investments changed year-over-year?
- Exelixis's short-term investments decreased by 35.0% year-over-year, from $847.56M to $551.06M.
- What is the long-term trend for Exelixis's short-term investments?
- Over 5 years (2020 to 2025), Exelixis's short-term investments has grown at a -8.3% compound annual growth rate (CAGR), from $887.32M to $576.6M.
- What does short-term investments mean?
- Liquid investments that the company can easily convert to cash within a year.
- How do you interpret short-term investments?
- High levels indicate strong liquidity and a capacity to fund R&D, while low levels may suggest a need for future financing.
- How does short-term investments compare across companies?
- High in biotech companies that have recently raised capital or are holding cash for long-term R&D pipelines.